-
Subthreshold doses of specific phosphodiesterase type 3 and 4 inhibitors enhance the pulmonary vasodilatory response to nebulized prostacyclin with improvement in gas exchange.
J Pharmacol Exp Ther. 2000 Feb;292(2):512-20
PMID: 10640287
-
The cGMP-specific phosphodiesterase inhibitor E4021 dilates the pulmonary circulation.
Am J Respir Crit Care Med. 1999 Sep;160(3):858-65
PMID: 10471609
-
A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group.
J Am Coll Cardiol. 2000 Jan;35(1):176-82
PMID: 10636277
-
Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group.
Ann Intern Med. 2000 Mar 21;132(6):435-43
PMID: 10733442
-
Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A.
Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3702-7
PMID: 10725373
-
Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension.
Anesthesiology. 2000 Jun;92(6):1702-12
PMID: 10839922
-
Sildenafil in primary pulmonary hypertension.
N Engl J Med. 2000 Nov 2;343(18):1342
PMID: 11183578
-
Expression of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in mouse tissues and cell lines using an antibody against the enzyme amino-terminal domain.
Biochim Biophys Acta. 2001 May 28;1539(1-2):16-27
PMID: 11389965
-
Urodilatin, a natriuretic peptide stimulating particulate guanylate cyclase, and the phosphodiesterase 5 inhibitor dipyridamole attenuate experimental pulmonary hypertension: synergism upon coapplication.
Am J Respir Cell Mol Biol. 2001 Aug;25(2):219-25
PMID: 11509332
-
Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension.
Circulation. 2001 Sep 11;104(11):1218-22
PMID: 11551870
-
Upregulation of phosphodiesterase 1A1 expression is associated with the development of nitrate tolerance.
Circulation. 2001 Nov 6;104(19):2338-43
PMID: 11696475
-
Cyclic nucleotide phosphodiesterase 1C promotes human arterial smooth muscle cell proliferation.
Circ Res. 2002 Feb 8;90(2):151-7
PMID: 11834707
-
Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.
Ann Intern Med. 2002 Apr 2;136(7):515-22
PMID: 11926786
-
Inhaled iloprost for severe pulmonary hypertension.
N Engl J Med. 2002 Aug 1;347(5):322-9
PMID: 12151469
-
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial.
Lancet. 2002 Sep 21;360(9337):895-900
PMID: 12354470
-
Pharmacokinetics and metabolism of infused versus inhaled iloprost in isolated rabbit lungs.
J Pharmacol Exp Ther. 2002 Nov;303(2):741-5
PMID: 12388660
-
Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil--review of the literature.
Eur J Med Res. 2002 Oct 29;7(10):435-46
PMID: 12435622
-
Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension.
Am J Respir Crit Care Med. 2003 Apr 15;167(8):1139-41
PMID: 12684251
-
Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension.
J Am Coll Cardiol. 2003 Jul 2;42(1):158-64
PMID: 12849677
-
Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study.
J Am Coll Cardiol. 2004 Oct 6;44(7):1488-96
PMID: 15464333
-
Biotransformation of the stable prostacyclin analogue, iloprost, in the rat.
Drug Metab Dispos. 1984 Sep-Oct;12(5):645-51
PMID: 6209077
-
Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial.
Ann Intern Med. 1990 Apr 1;112(7):485-91
PMID: 2107780
-
Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.
Ann Intern Med. 1991 Sep 1;115(5):343-9
PMID: 1863023
-
Phosphodiesterase inhibitors: new opportunities for the treatment of asthma.
Thorax. 1991 Jul;46(7):512-23
PMID: 1877039
-
Phosphodiesterase isozymes modulating inherent tone in human airways: identification and characterization.
Am J Physiol. 1993 May;264(5 Pt 1):L458-64
PMID: 7684572
-
Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors.
Am J Physiol. 1994 May;266(5 Pt 1):L536-43
PMID: 7515580
-
Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
Br J Pharmacol. 1994 Oct;113(2):445-50
PMID: 7834194
-
Diversity in cyclic nucleotide phosphodiesterase isoenzyme families.
Arch Biochem Biophys. 1995 Sep 10;322(1):1-13
PMID: 7574662
-
Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms.
Physiol Rev. 1995 Oct;75(4):725-48
PMID: 7480160
-
Inhibition of cyclic 3'-5'-guanosine monophosphate-specific phosphodiesterase selectively vasodilates the pulmonary circulation in chronically hypoxic rats.
J Clin Invest. 1996 Jan 1;97(1):172-9
PMID: 8550830
-
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.
N Engl J Med. 1996 Feb 1;334(5):296-301
PMID: 8532025
-
Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.
Ann Intern Med. 1996 May 1;124(9):820-4
PMID: 8610951
-
Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.
Int J Impot Res. 1996 Jun;8(2):47-52
PMID: 8858389
-
Ultrasonic nebulization for efficient delivery of surfactant in a model of acute lung injury. Impact on gas exchange.
Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):445-53
PMID: 9279222
-
Recent advances in the study of Ca2+/CaM-activated phosphodiesterases: expression and physiological functions.
Adv Second Messenger Phosphoprotein Res. 1997;31:237-51
PMID: 9344255
-
Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1C) is induced in human arterial smooth muscle cells of the synthetic, proliferative phenotype.
J Clin Invest. 1997 Nov 15;100(10):2611-21
PMID: 9366577
-
Altered expression of PDE1 and PDE4 cyclic nucleotide phosphodiesterase isoforms in 7-oxo-prostacyclin-preconditioned rat heart.
J Mol Cell Cardiol. 1997 Nov;29(11):3135-46
PMID: 9405187
-
Phosphodiesterase isozymes: molecular targets for novel antiasthma agents.
Am J Respir Crit Care Med. 1998 Feb;157(2):351-70
PMID: 9476844
-
Developmental changes in lung cGMP phosphodiesterase-5 activity, protein, and message.
Am J Respir Crit Care Med. 1998 Jul;158(1):279-88
PMID: 9655741
-
Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro.
Am J Cardiol. 1999 Mar 4;83(5A):3C-12C
PMID: 10078537
-
Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A.
Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):7071-6
PMID: 10359840
-
E-4010, a selective phosphodiesterase 5 inhibitor, attenuates hypoxic pulmonary hypertension in rats.
Am J Physiol. 1999 Aug;277(2 Pt 1):L225-32
PMID: 10444515
-
Low-dose systemic phosphodiesterase inhibitors amplify the pulmonary vasodilatory response to inhaled prostacyclin in experimental pulmonary hypertension.
Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 1):1500-6
PMID: 10556112